VEGFA and myopia: When anti-VEGF treatment is combined with LPC, the incidence of myopia changes drastically, with 7% of cases developing high myopia and 33% having low myopia after 2 to 3 years of follow-up in a cohort of 68 eyes in an American population [27,28].